April 2023

April 19, 2023
Dr. O'Dwyer and Dr. Schnall
April 19, 2023
Categories

From the Co-Chairs, April 2023

The ComboMATCH registration trial opens; NCI creates Clinical Trials Innovation unit, unveils revised National Cancer Plan
Do you like it?
0 Read more
April 19, 2023
ComboMATCH image
April 19, 2023
Categories

Now Enrolling: ECOG-ACRIN Opens the ComboMATCH Patient Registration Trial as the Gateway to a Coordinated Set of Treatment Trials

ComboMATCH researchers are discovering new drug combinations that show promise for patients with advanced cancers, based on strong pre-clinical in vivo evidence of therapeutic effectiveness
Do you like it?
0 Read more
April 19, 2023
Doctor and patient reviewing test results
April 19, 2023
Categories

Trial Spotlight: Kim Reiss on the EA2192/APOLLO Study for Certain Patients with Pancreatic Cancer

This phase 2 study is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
Do you like it?
0 Read more
April 19, 2023
Main Line Health logo
April 19, 2023
Categories

Institution Spotlight: Main Line Health and Lankenau Institute for Medical Research

A member of ECOG-ACRIN since 1973
Do you like it?
0 Read more
April 19, 2023
Research definition
April 19, 2023
Categories

Trial Results: ECOG-ACRIN Research Round-Up

Summaries of recently published ECOG-ACRIN research results
Do you like it?
0 Read more
April 19, 2023
News in Brief
April 19, 2023
Categories

News in Brief, April 2023

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
Do you like it?
0 Read more